Metsera (MTSR) | Stock Overview & Key Data

Metsera Inc. | Mid-cap | Healthcare

$32.80

1.90%

Metsera vs Vertex Metsera vs Regeneron Metsera vs BridgeBio Pharma Metsera vs Madrigal Metsera vs Blueprint Medicines Metsera vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Metsera Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Metsera	Healthcare Sector	S&P 500
1 Week	8.25%	N/A	N/A
1 Month	-17.82%	N/A	N/A
3 Months	14.37%	N/A	N/A
6 Months	3.63%	N/A	N/A
1 Year	23.77%	N/A	N/A
3 Years	23.77%	N/A	N/A
5 Years	23.77%	N/A	N/A

Stock Range

Today's Range

Low: $30.81 High: $33.41

on August 21, 2025

52 Week Range

Low: $12.30 High: $47.40

on April 9, 2025

on July 18, 2025

All-Time High: $47.40 on July 18, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $3.4B

EPS i -2.93

P/E Ratio (TTM) i -15.72

Forward P/E i -9.61

P/B Ratio i 7.56

PEG Ratio i -0.24

Div. Yield i N/A

ROE i -72.78%

Beta i N/A

Debt to Equity i 0.24

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 0.00%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -46.37%

Return on Equity (TTM) i -72.78%

EBITDA i $-223.7M

Net Income (TTM) i $-307.8M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i N/A

Quarterly Revenue Growth (YoY) i N/A

Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Metsera MTSR	3.40B Mid-cap	8.25%	-17.82%	14.37%	3.63%	23.77%	23.77%	23.77%	23.77%
Vertex VRTX	100.19B Large-cap	1.83%	-13.31%	-8.70%	-17.92%	-2.05%	-17.41%	41.10%	47.23%
Regeneron REGN	62.88B Large-cap	5.69%	9.65%	-1.07%	-14.59%	-16.36%	-50.12%	0.33%	-0.74%
BridgeBio Pharma BBIO	9.39B Mid-cap	-1.86%	9.43%	52.95%	36.31%	78.12%	98.46%	379.29%	69.75%
Madrigal MDGL	8.46B Mid-cap	9.62%	23.01%	46.84%	21.07%	29.74%	61.07%	481.06%	281.74%
Blueprint Medicines BPMC	8.37B Mid-cap	0.12%	1.05%	53.79%	15.63%	48.46%	12.60%	149.54%	73.38%

Ownership & Short Interest

Insider Ownership i 13.07%

Institutional Ownership i 84.09%

Shares Short i 10M

Short Ratio i 9.81

Short % of Shares Outstanding i 72.59%

Average 10-Day Volume i 1M

Average 90-Day Volume i 1M

Metsera Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Metsera would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of Metsera, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: 8.25%
1 Month: -17.82%
3 Months: 14.37%
1 Year: 23.77%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is MTSR's 52-week high and low?

In the last 52 weeks, Metsera reached a high of $47.40 (on July 18, 2025) and a low of $12.30 (on April 9, 2025).

What is the market cap and P/E ratio for MTSR?

Curious about Metsera's size and valuation? Its market capitalization stands at 3.40B. When it comes to valuation, the P/E ratio (trailing twelve months) is -15.72, and the forward P/E (looking ahead) is -9.61.

Does MTSR pay dividends? If so, what's the yield?

As for dividends, Metsera isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Metsera's main competitors or similar companies to consider before investing?

When looking at Metsera, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	100.19B	Healthcare	Biotechnology	-17.41%	41.10%
Regeneron REGN	62.88B	Healthcare	Biotechnology	-50.12%	0.33%
BridgeBio Pharma BBIO	9.39B	Healthcare	Biotechnology	98.46%	379.29%
Madrigal MDGL	8.46B	Healthcare	Biotechnology	61.07%	481.06%
Blueprint Medicines BPMC	8.37B	Healthcare	Biotechnology	12.60%	149.54%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Metsera Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Metsera's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -72.78%, the Debt to Equity ratio from the most recent quarter is 0.24, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for MTSR?

Looking at Metsera's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of MTSR stock is held by insiders and institutions?

Wondering who owns Metsera stock? Company insiders (like executives and directors) hold about 13.07% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 84.09%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.